Cannabis remains a schedule 1 drug under federal law but do the feds really think that cannabis is as dangerous as its fellow schedule 1 drugs such as heroin? As cannabis becomes legalized in many states, it comes difficult to understand how the government can still believe that cannabis is as dangerous as harder drugs.
Schedule 1 drugs are considered to be the most dangerous and harmful drugs. These drugs are also considered to have no medical use with a high potential for abuse. Other schedule 1 drugs include heroin, peyote, methylenedioxymethamphetamine (ecstasy) and lysergic acid diethylamide (LSD). Schedule 1 drugs taken thousands of lives all over the world each year and countless lives throughout history, yet cannabis has never claimed a life.
Cannabis has proven its medicinal value over and over again. It has also proven to be the least harmful and most effective drug out there, whether compared to recreational drugs or to pharmaceutical drugs. The fact that it is still classified as a schedule 1 drug under federal law is infuriating cannabis users, advocates and professionals.
Despite its’ worth and legalization spreading, there are currently no signs that anything cannabis-related will be taken off that list. The simple answer is that federal agencies do not think that cannabis is as dangerous as other schedule drugs, but rather that it has no medical value. I know, this doesn’t make much sense to me either given how much research is available that claims otherwise.
Veriheal has satisfied millions of patients nationwide by giving them access to these benefits
The U.S Food and Drug Administration (FDA) would require extensive and comprehensive clinical trials, the same way as any other drug, in order to determine the medical value of cannabis. This can involve several years and costs that average around $19 Million. In order to even get this going, professionals would have to claim and prove that their cannabis strain can certainly heal or drastically assist with a condition such as curing/inhibiting epilepsy entirely. This is simply how the government’s drug approval process operates.
Even if a company can succeed in this process its cannabis strain, which will most likely be made into a pharmaceutical form such as a pill, will only be allowed to be prescribed to patients with the same condition that the FDA process was done with. If the same company can lay claims and proof that another or the same of their product can be useful for another condition, they will have to embark on more extensive and comprehensive clinical trials to prove it.
Cannabis, LSD, ecstasy, and heroin may be in the same schedule 1 drug classification, but that does not mean that the federal agencies believe cannabis is as dangerous as those other drugs. The basics are that no one has been able to come forward with definitive evidence proving the cannabis medicinal value. When this does eventually happen, we believe it will, professionals believe that cannabis will likely only be reduced to a schedule V drug. This means that cannabis can be prescribed by doctors and accessed in pharmacies but it will be strictly controlled.
Alternatively, cannabis can get off of the schedule 1 drug list if it were to be removed from the federal government list, ending cannabis prohibition nationwide and essentially allowing cannabis to be used similarly to how alcohol and tobacco are allowed. This may be the easiest way to get cannabis off that list instead of embarking on the expensive and extensive clinical trials to definitively prove its medical value.
For now, we can not tell which way it will go. Will federal agencies end the cannabis prohibition, or will professionals step up to take on the FDA process? Either way, there is at least some comfort in knowing the fact that the feds do not think that cannabis is as dangerous as the other schedule 1 drugs.
With the arrival of 4/20 comes the promise of festivals, mass smoke sessions, and camaraderie with fellow cannabis enthusiasts. But, while cannabis may promote social gathering for some, others prefer to consume their cannabis in the way of the introvert – that is, completely alone. If you’re not exactly a social smoker and still want…
It’s become increasingly common to hear stories of those suffering from serotonin syndrome, but for some, the full scope and depth of this mysterious condition remain shrouded in mystery. Are psychedelic drugs and cannabis capable of triggering this serious medical issue? In this post, we’ll dive into what serotonin syndrome is, how you may be…
The legendary stoner holiday 4/20 is upon us, and so are the transits and astrological happenings associated with it. As spring and warm weather begin to roll in, spirits lift, and people spend more time outside under the sun—and, of course, the stars. Smoking under the night sky is a thrilling experience. Whether you’re a…
Hash is more than just a hot trend with ancient origins: it’s the future of medical cannabis consumption. Because this form of concentrate is deliberately engineered to preserve the natural terpenes and cannabinoid profile of the cannabis plant, dabbing hash is perhaps the most efficient way to seek the potential benefits of medical marijuana –…
Cannabis use is increasing all around the world. The American marijuana industry was worth about $57 billion in 2023 and is projected to reach $444 billion by 2030, a staggering growth that reflects it as the fastest-growing industry anywhere in the world. Veriheal consistently stays abreast of current trends by conducting routine surveys among our…
Get your medical marijuana card today
Sign up in under 5 minutes
